abiraterone acetate

Generic: abiraterone

Labeler: american health packaging
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abiraterone acetate
Generic Name abiraterone
Labeler american health packaging
Dosage Form TABLET
Routes
ORAL
Active Ingredients

abiraterone acetate 250 mg/1

Manufacturer
American Health Packaging

Identifiers & Regulatory

Product NDC 60687-790
Product ID 60687-790_2f0ff61e-95d0-1f19-e063-6294a90a2e7b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208327
Listing Expiration 2026-12-31
Marketing Start 2024-07-31

Pharmacologic Class

Classes
cytochrome p450 17a1 inhibitor [epc] cytochrome p450 17a1 inhibitors [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 60687790
Hyphenated Format 60687-790

Supplemental Identifiers

RxCUI
1100075
UNII
EM5OCB9YJ6

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abiraterone acetate (source: ndc)
Generic Name abiraterone (source: ndc)
Application Number ANDA208327 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 30 BLISTER PACK in 1 CARTON (60687-790-21) / 1 TABLET in 1 BLISTER PACK (60687-790-11)
source: ndc

Packages (1)

Ingredients (1)

abiraterone acetate (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2f0ff61e-95d0-1f19-e063-6294a90a2e7b", "openfda": {"unii": ["EM5OCB9YJ6"], "rxcui": ["1100075"], "spl_set_id": ["b36bff33-595e-4827-9a73-85c6954c314c"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (60687-790-21)  / 1 TABLET in 1 BLISTER PACK (60687-790-11)", "package_ndc": "60687-790-21", "marketing_start_date": "20240731"}], "brand_name": "Abiraterone Acetate", "product_id": "60687-790_2f0ff61e-95d0-1f19-e063-6294a90a2e7b", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "60687-790", "generic_name": "Abiraterone", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abiraterone Acetate", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "250 mg/1"}], "application_number": "ANDA208327", "marketing_category": "ANDA", "marketing_start_date": "20240731", "listing_expiration_date": "20261231"}